Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer



Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus

Volume:20   Issue: 10
Pp: 995-1007
Amira Mohamed Mohsen*
DOI: 10.2174/1389450120666190307101642



Nano Drug Delivery in Treatment of Oral Cancer, A Review of the Literature

Volume:20   Issue: 10
Pp: 1008-1017
Vandita Kakkar*, Manoj Kumar Verma, Komal Saini and Indu Pal Kaur
DOI: 10.2174/1389450120666190319125734



Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression

Volume:20   Issue: 10
Pp: 1018-1028
Jun-Chen Li, Xing Chang, Yang Chen, Xin-Zhe Li, Xiang-Lian Zhang, Shi-Ming Yang, Chang-Jiang Hu* and Hao Zhang*
DOI: 10.2174/1389450120666190227184654



The Use of Naltrexone in Dermatology. Current Evidence and Future Directions

Volume:20   Issue: 10
Pp: 1058-1067
Mariusz Sikora*, Adriana Rakowska, Małgorzata Olszewska and Lidia Rudnicka
DOI: 10.2174/1389450120666190318121122



NOB1: A Potential Biomarker or Target in Cancer

Volume:20   Issue: 10
Pp: 1081-1089
Weiwei Ke, Zaiming Lu and Xiangxuan Zhao*
DOI: 10.2174/1389450120666190308145346